BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 12, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Financings for Aug. 31, 2020

Aug. 31, 2020
Med-tech firms raising money in public or private financings, including: Aereus Technologies, Vessi Medical.
Read More

Appointments and advancements for Aug. 31, 2020

Aug. 31, 2020
New hires and promotions in the med-tech industry, including: Mannkind.
Read More

In the clinic for Aug. 31, 2020

Aug. 31, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acasti, Akari, Axsome, Bluebird, Eiger, Embera, GSK, Imbrium, Kiadis, Maat, Mirum, NGM, Novan, Novartis, Orpheris, Provention, Regenerx, Shattuck, VBI, Vir.
Read More

Financings for Aug. 31, 2020

Aug. 31, 2020
Biopharmas raising money in public or private financings, including: Biodol, Cohbar, Compass, Pyramid, Tracon.
Read More

Appointments and advancements for Aug. 31, 2020

Aug. 31, 2020
New hires and promotions in the biopharma industry, including: Acadia, Eton, Mannkind, Mersana, Onconova, Recce, Turning Point, Xortx.
Read More

Regulatory actions for Aug. 31, 2020

Aug. 31, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biocryst, Can-Fite, Cormedix, Cstone, FDS, Gilead, Lipocine, Mustang, Omeros, Oncopeptides, Revive, Sound, Spero, Velosbio, Xortx.
Read More

Regulatory actions for Aug. 28, 2020

Aug. 28, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Synchron.
Read More

Other news to note for Aug. 28, 2020

Aug. 28, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ambu, Apex Management Solutions, Eqhealth Solutions, Kc Wearable, Leica Microsystems, Medcare Supplies, Medx Health, Mellingmedical, My Solid Technologies & Devices, Philips, Premier, Roqu Group, Stryker, Thermo Fisher Scientific, Wright Medical Group.
Read More

Financings for Aug. 28, 2020

Aug. 28, 2020
Med-tech firms raising money in public or private financings, including: Motus GI, Movano.
Read More

Appointments and advancements for Aug. 28, 2020

Aug. 28, 2020
New hires and promotions in the med-tech industry, including: Ibex Technologies.
Read More
Previous 1 2 … 1477 1478 1479 1480 1481 1482 1483 1484 1485 … 1734 1735 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 12, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 12, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld Science
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • LINC01116 has prognostic value in lung cancer, study shows

    BioWorld Science
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing